HDR-192Ir intraluminal brachytherapy in treatment of malignant obstructive jaundice

Table 1 Baseline clinical characteristics of patients

Factor	Group A (n = 14)	Group B (n = 20)	P
Mean age (yr)	57.9 ± 9.2	63.3 ± 11.4	0.356
Gender
Male	8	10	0.681
Female	6	10
Mean total serum bilirubin	318 ± 94	314 ± 115	0.913
concentration (μmol/L)
Mean alanine	71 ± 52	106 ± 107	0.261
aminotransferase concentration (U/L)
Mean albumin	33.6 ± 4.3	33.5 ± 3.4	0.914
concentration (g/L)
Mean alkaline	443 ± 334	543 ± 400	0.449
phosphatase (U/L)
Mean hemoglobin	111 ± 12	105 ± 16	0.275
concentration (g/L)
Mean obstructive	3.7 ± 0.9	4.0 ± 1.4	0.512
duration (wk)
Obstructive level
Hilar	8	12	0.868
Common bile duct	6	8
TACE
Performed	9	10	0.409
Not performed	5	10